5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.09▲ | 3.06▲ | 3.05▲ | 3.21▼ | 2.91▲ |
MA10 | 3.08▲ | 3.05▲ | 3.06▲ | 2.96▲ | 2.59▲ |
MA20 | 3.06▲ | 3.06▲ | 3.16▼ | 2.86▲ | 2.25▲ |
MA50 | 3.04▲ | 3.20▼ | 3.06▲ | 2.50▲ | 3.24▼ |
MA100 | 3.06▲ | 3.02▲ | 2.82▲ | 2.24▲ | 3.78▼ |
MA200 | 3.18▼ | 2.79▲ | 2.87▲ | 2.90▲ | 3.94▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.010▲ | -0.022▼ | 0.026▲ | 0.207▲ |
RSI | 68.019▲ | 50.281▲ | 48.707▼ | 56.764▲ | 56.647▲ |
STOCH | 94.167▲ | 63.928 | 37.401 | 74.670 | 82.864▲ |
WILL %R | 0.000▲ | -7.407▲ | -62.121 | -33.333 | -17.512▲ |
CCI | 120.645▲ | 123.810▲ | -11.425 | 57.331 | 105.527▲ |
Thursday, August 18, 2022 05:32 AM
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) price on Wednesday, August 17, fall -6.71% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.06. A look at the ...
|
Tuesday, August 16, 2022 03:06 AM
Los Angeles Capital Management LLC grew its position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) by 19.9% in the first quarter, according to its most recent 13F filing with the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/08/22 | 3.02 | 3.10 | 2.975 | 3.10 | 861,182 |
17/08/22 | 3.22 | 3.31 | 3.06 | 3.06 | 1,409,260 |
16/08/22 | 3.48 | 3.48 | 3.25 | 3.28 | 1,061,668 |
15/08/22 | 3.18 | 3.455 | 3.15 | 3.43 | 1,639,139 |
12/08/22 | 2.90 | 3.27 | 2.79 | 3.17 | 3,264,200 |
11/08/22 | 2.77 | 2.86 | 2.71 | 2.76 | 1,193,000 |
10/08/22 | 2.65 | 2.81 | 2.59 | 2.78 | 1,217,100 |
09/08/22 | 2.67 | 2.67 | 2.50 | 2.56 | 1,266,300 |
08/08/22 | 2.87 | 3.02 | 2.47 | 2.58 | 2,882,700 |
05/08/22 | 2.62 | 2.88 | 2.60 | 2.83 | 2,739,700 |
|
|
||||
|
|
||||
|
|